Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy

Launched by THE UNIVERSITY OF HONG KONG · Jul 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of using artificial intelligence (AI) to assist in upper gastrointestinal endoscopy, a procedure where a doctor looks inside the stomach using a thin, flexible tube with a camera. The goal is to see if AI can help find gastric neoplasms, which are abnormal growths in the stomach, more accurately than traditional high-definition endoscopy. Researchers believe that the AI-assisted method may miss fewer cases of these growths compared to the standard approach.

To participate in this trial, individuals must be 40 years or older and scheduled for an elective upper endoscopy. However, pregnant women, those who cannot give consent, individuals who have had stomach surgery, or patients with serious health issues that make the procedure risky will not be eligible. If you join the trial, you can expect to undergo the endoscopy with either the AI-assisted method or the standard method, and your experience will help researchers learn more about improving the detection of stomach growths.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 40 or older
• • Scheduled for elective upper endoscopy
• Exclusion Criteria:
• • Pregnant women,
• • Inability to provide written informed consent
• • Prior gastrectomy, and
• • Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses